Investigating mono vs dual therapy for pediatric pulmonary arterial hypertension ...

ADHD with ASD and without it: Should they be treated differently?

ADHD with ASD and without it: Should they be treated differently?

The designations follow the FDA acceptance of IND application for ABO-101 to treat PH1, with a phase 1/2 study planned in the first half of 2025. The FDA has granted a pair of designations, both ...

A new study published in BMC Pediatrics highlights the significant role parents play in shaping their children's media consumption, particularly when it comes to exposure to mature content such as ...

A study presented at the American Academy of Pediatrics 2024 National Conference finds children with disabilities in foster care face lower permanency rates and higher mortality risks, calling for ...

New research has identified novel rhinoconjunctivitis phenotypes in children with asthma which may not be allergy-driven, prompting the need for more research to better understand the pathology of ...

A loot into nutrition's role in acne care, highlighted by Colleen Sloan, PA-C, RDN. Acne is a common yet frustrating condition that affects nearly 85% of teenagers, often affecting their self-esteem ...

The primary and all key secondary endpoints were met compared to cream vehicle in the phase 3 DELTA TEEN trial. LEO Pharma A/S has reported positive phase 3 data for delgocitinib (Anzupgo) 20 mg /g ...

Panelists discuss the 2023 American Academy of Allergy, Asthma & Immunology/ American College of Allergy, Asthma & Immunology (AAAAI/ACAAI) Joint Task Force guidelines, highlighting treatment options ...

Navigating the ever-evolving landscape of pediatric care means staying ahead of clinical developments, regulatory shifts, and therapeutic breakthroughs—each with the potential to reshape how we ...

Needle-free treatments, such as Neffy and FluMist, offer promising alternatives for children and adults with needle phobia, ensuring access to critical care.